Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection.
about
Imaging Based Methods of Liver Fibrosis Assessment in Viral Hepatitis: A Practical ApproachNon-invasive diagnosis of liver fibrosis in chronic hepatitis CValue of 3 Tesla diffusion-weighted magnetic resonance imaging for assessing liver fibrosis.Cationized ferritin as a magnetic resonance imaging probe to detect microstructural changes in a rat model of non-alcoholic steatohepatitis.Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data.Usefulness of non-invasive markers for predicting significant fibrosis in patients with chronic liver diseaseIdentification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers.Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis CRole of simple biomarkers in predicting fibrosis progression in HCV infection.Liver biopsy for histological assessment: The case against.Transjugular liver biopsy: how good is it for accurate histological interpretation?Transjugular liver biopsy in patients with diffuse liver disease: comparison of three cores with one or two cores for accurate histological interpretation.Correlation of Laparoscopic Liver Biopsy to Elasticity Measurements (FibroScan) in Patients With Chronic Liver DiseaseProspective Evaluation of FIBROSpect II for Fibrosis Detection in Hepatitis C and B Patients Undergoing Laparoscopic Biopsy.Hepatitis C and kidney transplantationIs the neutrophil to lymphocyte ratio associated with liver fibrosis in patients with chronic hepatitis B?An appraisal of the histopathological assessment of liver fibrosisVariability of grade and stage in simultaneous paired liver biopsies in patients with hepatitis C.Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infectionImproving the treatment of hepatitis C infection in the UK.A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C.Assessing liver fibrosis.Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.Non-invasive assessment of fibrosis in liver grafts due to hepatitis C virus recurrence.Cirrhosis regression in hepatitis C patients with sustained virological response after antiviral therapy: a meta-analysis.Extended follow-up of pediatric liver transplantation patients receiving once daily calcineurin inhibitor.Are non-invasive fibrosis markers for chronic hepatitis B reliable in sub-Saharan Africa?Multiparametric or practical quantitative liver MRI: towards millisecond, fat fraction, kilopascal and function era.Hepatic venous pressure gradient correlates with advanced hepatic fibrosis: a retrospective review.Liver collagen in cirrhosis correlates with portal hypertension and liver dysfunction.Genomics and proteomics in liver fibrosis and cirrhosis.Sampling variability of computer-aided fractal-corrected measures of liver fibrosis in needle biopsy specimensThe diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis.Serum autofluorescence, a potential serum marker for the diagnosis of liver fibrosis in rats.Sources of variability in histological scoring of chronic viral hepatitis.High-risk nodules detected in the hepatobiliary phase of Gd-EOB-DTPA-enhanced MR imaging in cirrhosis or chronic hepatitis: incidence and predictive factors for hypervascular transformation, preliminary results.YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection.Transient elastography for patients with chronic hepatitis B and C virus infection: Non-invasive, quantitative assessment of liver fibrosis.Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive index.Computational identification of microRNAs and their targets in liver cirrhosis.
P2860
Q26771433-B380CF01-91D4-4952-8C57-FC6551AE60EAQ26865956-6E8ECFF9-BFAA-4A73-A14E-6C90568B1FFDQ30420473-B4309614-7E97-4442-ABCB-1540F0FDA0AFQ30426246-B5D74785-0088-4D89-8893-9E9450964A1CQ30877287-A9383CF6-D4F7-4CAC-ABED-6FBFA2CF0278Q33565557-DE51A203-672E-44B3-9ACF-4F87EA021E07Q33671532-5FFBFF73-BB35-446A-A2E7-0A9BDB4F260EQ33866681-B02CE5C0-C44A-48CA-9030-2BC7040B9396Q34385138-9835E6B4-359F-4451-9B1B-DBC21977E501Q34469006-129C42D3-4CBC-46EF-833E-DE846891311FQ34517172-4842059D-2941-489D-AFC1-17C9171CB06FQ34627798-D94856FF-ACBD-41BF-B9E0-FF129FD44BDCQ34978447-F243B4F1-8CC7-4127-8832-12D2370F1074Q34996766-3FED1DF3-4201-4718-935D-9498B78C6F5AQ35094769-C1DA0C31-A382-40C6-88E1-DF661D9D7CAEQ35594244-986FAF2C-D67F-497E-B17A-B85F2DA2F33CQ35760393-6C0AE3BB-A3B6-4DB8-92BA-91D7979B276BQ35770548-47BBC213-EFF7-4804-AFA4-2ED807021D86Q35981177-83D0BA07-CA02-4A25-ACED-32FDC9AB7448Q36719683-10FCC0D8-D4B1-4548-BB23-F11C66DD4C46Q37090659-12611721-4D8A-4240-AB40-1245859CE09EQ37345958-3A30CEE3-0099-43D5-A7DA-823846C32853Q37405449-886ACBBE-C794-4DFF-ADEA-6D04C119423FQ37868672-DA156BAE-74C2-4C43-BDFD-3858242A4938Q38207083-0AD53B26-15C4-4635-BF87-69A1CA2BBD30Q38563334-8582B6C1-942A-476B-A82B-D984DBC06768Q38970883-BEE797CC-C8B4-4FB4-8389-03C896BC9DEDQ39034532-084C317E-B559-4C27-88E0-3D505F7DD525Q39285089-FD63C6E1-75E5-473B-92A3-C7CE31E74F85Q40209617-444DE376-A1FC-482F-95DA-CE4B55725710Q40462698-6E28962E-C281-4C5B-8F30-80BF70B52781Q42068846-3637E513-8BAE-4C55-BCB8-82E2B0FF03B3Q42241447-2F395240-77C0-469C-9350-5DDF4529F7DDQ42250966-6E317BBB-5F2E-46C1-809A-0EF0E7492E5BQ43816595-2863EF07-3F0C-4748-95EC-A9BD4FE1FB76Q44480005-4FE0BADF-EC66-41D7-A2A8-FB9BE8122088Q44809014-4D7112BC-09A3-4AAA-9800-838F1253DF13Q45402326-9728ED88-28FC-4C94-B13E-544A9AED29AEQ46388769-548DBFC9-9BA6-466F-888F-E757CA906341Q47099635-2E03389C-D5A1-442E-ABC9-25A6A3F20FFC
P2860
Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Sampling variability on percut ...... c hepatitis C virus infection.
@en
Sampling variability on percut ...... c hepatitis C virus infection.
@nl
type
label
Sampling variability on percut ...... c hepatitis C virus infection.
@en
Sampling variability on percut ...... c hepatitis C virus infection.
@nl
prefLabel
Sampling variability on percut ...... c hepatitis C virus infection.
@en
Sampling variability on percut ...... c hepatitis C virus infection.
@nl
P2093
P2860
P1476
Sampling variability on percut ...... c hepatitis C virus infection.
@en
P2093
P2860
P304
P356
10.1080/00365520310000825
P577
2003-04-01T00:00:00Z